Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 128 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Smith BH, Fletcher EH, Calvin LA. Opioid prescribing is rising in many countries. BMJ 2019;367:17 de octubre. [Ref.ID 103203]
2. Cita con resumen
Wei L, Ratnayake L, Phillips G, McGuigan CC, Morant SV, Flynn RW, Mackenzie IS, MacDonald TM. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study. Br J Clin Pharmacol 2017;83:1298-308. [Ref.ID 101942]
3. Cita con resumen
Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D, Ritchie L, Mackenzie J, Bennie M. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ 2016;354:i4079. [Ref.ID 100606]
5. Cita con resumen
Spence D. Bad medicine: nalmefene in alcohol misuse. BMJ 2014;348:g1531. [Ref.ID 97333]
6. Cita con resumen
Anónimo. Drug assessment: UK style. Drug Ther Bull 2013;51:141-4. [Ref.ID 96627]
8. Cita con resumen
Short PM, Lipworth SIW, Elder DHJ, Schembri S, Lipworth BJ. Effect of ß blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ 2011;342:2549. [Ref.ID 90568]
9.Tiene citas relacionadas Cita con resumen
Macaulay D. Glucagon-like peptide-1 drugs. Are GLP-1 analogues affordable?. BMJ 2011;342:563. [Ref.ID 90293]
11. Cita con resumen
Anónimo. Risque de cancers chez des patients diabétiques traités par insuline glargine?. Prescrire 2010;30:268-70. [Ref.ID 88326]
12. Cita con resumen
de Andrade M. In clear sight. BMJ 2009;339:538-40. [Ref.ID 86726]
13.Tiene citas relacionadas Cita con resumen
Gale EAM. Insulin glargine and cancer: another side. Lancet 2009;374:521. [Ref.ID 86486]
14.Tiene citas relacionadas Cita con resumen
Pocock SJ, Smeeth L. Insulin glargine and malignancy: an unwarranted alarm. Lancet 2009;374:511-3. [Ref.ID 86414]
16.Tiene citas relacionadas Cita con resumen
Colhoun HM, on behalf of the SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: A study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2009;52:1755-65. [Ref.ID 86108]
17.Enlace a cita originalTiene citas relacionadas Cita con resumen
Smith U, Gale EAM. Does diabetes therapy influence the risk of cancer?. Diabetologia 2009;52:1699-708. [Ref.ID 86102]
18. Cita con resumen
Ball DR, Kamel Y, Perkins V. Entanglement in Scotland. BMJ 2009;338:494. [Ref.ID 85382]
20.Tiene citas relacionadas Cita con resumen
Stanley AJ, Ashley D, Dalton HR, Mowat C, Gaya DR, Thompson E, Warshow U, Groome M, Cahill A, Benson G, Blatchford O, Murray W. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet 2009;373:42-7. [Ref.ID 84955]
Seleccionar todas
 
 1 a 20 de 128 siguiente >>